Nanzigu, SarahKiguba, RonaldKabanda, JosephMukonzo, Jackson K .Waako, PaulKityo, CissyMakumbi, Fred2021-12-152021-12-152013Nanzigu, S., Kiguba, R., Kabanda, J., Mukonzo, JK, Waako, P., Kityo, C., & Makumbi, F. (2013). Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. HIV / AIDS (Auckland, NZ) , 5 , 309. http://dx.doi.org/10.2147/HIV.S50614http://dx.doi.org/10.2147/HIV.S50614https://nru.uncst.go.ug/xmlui/handle/123456789/539With access to antiretroviral therapy (ART) expanding in resource-limited settings, assessing factors related to clinical, immunological, and virological outcomes of ART is of great importance. Even though ART is loosely referred to as a lifelong treatment, clinical, immunological and virological outcome measures differ among patients on highly active ART (HAART), with differences reported within and across cohorts.1–6 Mortality is among the ART-outcome variables that have been studied extensively, and rates of up to 30% have been reported during the first year of treatment in some sub-Saharan settingsenBaseline CD4 cellsHIV severityImmunological recoveryART outcomeARTArticle